JNCE Crosses Above Average Analyst Target
January 21, 2021 at 08:21 AM EST
In recent trading, shares of Jounce Therapeutics Inc (JNCE) have crossed above the average analyst 12-month target price of $11.33, changing hands for $11.35/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..